Vanguard Fiduciary Trust
SER icon

Vanguard Fiduciary Trust’s Serina Therapeutics SER Stock Holding History

Vanguard Fiduciary Trust’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.8K Hold
20,009
– – ﹤0.01% 3916
2026
Q1 		$38.8K Buy
+20,009
New +$44K ﹤0.01% 3871

Other funds holding SER

SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WA
Waverly Advisors Birmingham, Alabama $17.2B AUM 24.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AWE
Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.8% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Vanguard Fiduciary Trust's SER Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its Serina Therapeutics (SER) position steady in Q2 2026 at 20,009 shares worth $38.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3916.

Vanguard Fiduciary Trust first reported a position in SER in Q1 2026 and has held it in 2 quarters since. 27 funds tracked by Wall St. Rank hold SER as of Q2 2026.

  • Vanguard Fiduciary Trust held 20,009 shares of Serina Therapeutics worth $38.8K as of Q2 2026.
  • Vanguard Fiduciary Trust left its Serina Therapeutics share count unchanged in Q2 2026.
  • Serina Therapeutics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3916 holding.
  • Vanguard Fiduciary Trust first reported a position in Serina Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 27 funds tracked by Wall St. Rank held Serina Therapeutics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.